- Home
- FOLD vs CON Comparison
FOLD vs CON Comparison
Compare FOLD & CON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- CON
- Stock Information
- Founded
- FOLD 2002
- CON 1979
- Country
- FOLD United States
- CON United States
- Employees
- FOLD N/A
- CON N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- CON
- Sector
- FOLD Health Care
- CON
- Exchange
- FOLD Nasdaq
- CON NYSE
- Market Cap
- FOLD 2.8B
- CON 2.6B
- IPO Year
- FOLD 2007
- CON 2024
- Fundamental
- Price
- FOLD $9.50
- CON $21.44
- Analyst Decision
- FOLD Strong Buy
- CON Strong Buy
- Analyst Count
- FOLD 8
- CON 7
- Target Price
- FOLD $17.57
- CON $28.71
- AVG Volume (30 Days)
- FOLD 2.4M
- CON 450.9K
- Earning Date
- FOLD 11-06-2024
- CON 10-31-2024
- Dividend Yield
- FOLD N/A
- CON 1.17%
- EPS Growth
- FOLD N/A
- CON 0.28
- EPS
- FOLD N/A
- CON 1.59
- Revenue
- FOLD $493,671,000.00
- CON $1,875,891,000.00
- Revenue This Year
- FOLD $33.97
- CON $4.24
- Revenue Next Year
- FOLD $21.74
- CON $5.64
- P/E Ratio
- FOLD N/A
- CON $13.45
- Revenue Growth
- FOLD 32.58
- CON 8.79
- 52 Week Low
- FOLD $9.02
- CON $18.89
- 52 Week High
- FOLD $14.57
- CON $24.81
- Technical
- Relative Strength Index (RSI)
- FOLD 28.33
- CON N/A
- Support Level
- FOLD $9.37
- CON N/A
- Resistance Level
- FOLD $9.68
- CON N/A
- Average True Range (ATR)
- FOLD 0.49
- CON 0.00
- MACD
- FOLD -0.18
- CON 0.00
- Stochastic Oscillator
- FOLD 3.96
- CON 0.00
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About CON CONCENTRA GROUP HOLDINGS PARENT INC
Concentra Group Holdings Parent Inc is a company providing occupational and consumer health services through occupational health centers and onsite clinics. Their services include workers' compensation injury care, employer services, urgent care, clinical testing, wellness programs, and preventative care.